AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 120 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.28 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $423,000 | +78.5% | 6,344 | +37.8% | 0.00% | +100.0% |
| Q2 2017 | $237,000 | -59.8% | 4,604 | -54.4% | 0.00% | -50.0% |
| Q1 2017 | $590,000 | +47.1% | 10,104 | +5.2% | 0.00% | 0.0% |
| Q4 2016 | $401,000 | -20.9% | 9,604 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $507,000 | +162.7% | 9,604 | +108.6% | 0.00% | +100.0% |
| Q2 2016 | $193,000 | +3.2% | 4,604 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $187,000 | -37.5% | 4,604 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $299,000 | -8.0% | 4,604 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $325,000 | -36.5% | 4,604 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $512,000 | -68.3% | 4,604 | -73.1% | 0.00% | -71.4% |
| Q1 2015 | $1,616,000 | -17.7% | 17,141 | -2.2% | 0.01% | -12.5% |
| Q4 2014 | $1,964,000 | +43.1% | 17,526 | -21.6% | 0.01% | +33.3% |
| Q3 2014 | $1,372,000 | +34.1% | 22,365 | +0.2% | 0.01% | +50.0% |
| Q2 2014 | $1,023,000 | +36.0% | 22,319 | +16.3% | 0.00% | +33.3% |
| Q1 2014 | $752,000 | +45.5% | 19,196 | -11.1% | 0.00% | +50.0% |
| Q4 2013 | $517,000 | +17.2% | 21,600 | +36.8% | 0.00% | 0.0% |
| Q3 2013 | $441,000 | – | 15,785 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |